• MURAGLITAZAR CHEMBL186179

    Alternate Names:

    Muraglitazar
    BMS-298585
    N-[[4-METHOXYPHENOXY)CARBONYL]-N-[(4-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)-ETHOXY]PHENYL]METHYL]GLYCINE
    2-[(4-METHOXYPHENOXYCARBONYL)({4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL}METHYL)AMINO]ACETIC ACID
    2-[(4-METHOXYPHENOXYCARBONYL)({3-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL}METHYL)AMINO]ACETIC ACID
    2-[(4-METHOXYPHENOXY)CARBONYL-[[4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)ETHOXY]PHENYL]METHYL]AMINO]ACETIC ACID
    ((4-METHOXY-PHENOXYCARBONYL)-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-BENZYL}-AMINO)-ACETIC ACID
    [C14]-2-((4-METHOXYPHENOXY)CARBONYL)ACETIC ACID
    D05091
    FT-0672555
    CAS-331741-94-7
    RT-013967
    LS-190838
    KB-145972
    HE335744
    HE070879
    NCGC00262954-01
    AN-5859
    ZINC49650290
    DNC005671
    BDBM50150998
    TOX21_113946
    IRLWJILLXJGJTD-UHFFFAOYSA-N
    CTK8E8901
    CCRIS 9258
    SCHEMBL676469
    DSSTOX_GSID_57719
    DSSTOX_RID_97393
    DSSTOX_CID_31508
    MURAGLITAZAR (USAN/INN)
    W1MKM70WQI
    AC1L4FVP
    MURAGLITAZAR [USAN]
    BMS298585
    N-[(4-METHOXYPHENOXY)CARBONYL]-N-[[4-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHOXY]PHENYL]METHYL]GLYCINE
    N-((4-METHOXYPHENOXY)CARBONYL)-N-((4-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHOXY)PHENYL)METHYL)GLYCINE
    2-[(4-METHOXYPHENOXY)CARBONYL-[[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]METHYL]AMINO]ACETIC ACID
    BMS 298585
    UNII-W1MKM70WQI
    331741-94-7
    PARGLUVA
    206044
    PA162356187

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antidiabetic
    Drug Type drug/small molecule
    (0 More Sources)

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Mechanism of Interaction Peroxisome proliferator-activated receptor gamma agonist
    Direct Interaction yes
    Trial Name muraglitazar, BMS-298585

    Publications:

  • Interaction Types:
    agonist

    Interaction Info:
    Trial Name muraglitazar, BMS-298585
    Novel drug target Established target
    Mechanism of Interaction Peroxisome proliferator-activated receptor alpha agonist

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

  • Interaction Types:
    n/a

    Interaction Info:

    Publications:

    • Version: 12-July-2012

    Alternate Names:
    MURAGLITAZAR Primary Drug Name
    PA162356187 PharmGKB Drug Accession

    Drug Info:
    Drug Type drug/small molecule

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antidiabetic
    Drug Class Small molecule
    FDA Approval not approved

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    MURAGLITAZAR pubchem_primary_name
    206044 PubChem CID
    PARGLUVA Drug Synonym

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: